REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioximad S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Other Ambulatory Health Care Services
Full name: Bioximad S.A.S. Profile Updated: March 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Bioximad S.A.S. is based in Colombia, with the head office in La Estrella. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on March 26, 2012. It currently has a total number of 27 (2025) employees. There was a net sales revenue increase of 17.32% reported in Bioximad S.A.S.’s latest financial highlights for 2024. A growth of 14.51% was recorded in its total assets. The net profit margin of Bioximad S.A.S. decreased by 3.26% in 2024.

Headquarters
Cr 55 # 79B Sur 40
La Estrella; Antioquia;

Contact Details: Purchase the Bioximad S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Bioximad S.A.S. report to view the information.
Financial Auditors:
Purchase the Bioximad S.A.S. report to view the information.
Incorporation Date:
March 26, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bioximad S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.32%
Total operating revenue
17.32%
EBITDA
-57.57%
Net Profit (Loss) for the Period
-36.62%
Total Assets
14.51%
Total Equity
22.83%
Net Profit Margin
-3.26%
Return on Equity (ROE)
-17.44%
Quick Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?